Development of a Label-Free Immunosensor for Clusterin Detection as an Alzheimer’s Biomarker

Clusterin (CLU) has been associated with the clinical progression of Alzheimer’s disease (AD) and described as a potential AD biomarker in blood plasma. Due to the enormous attention given to cerebrospinal fluid (CSF) biomarkers for the past couple of decades, recently found blood-based AD biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Islam, Kamrul, Damiati, Samar, Sethi, Jagriti, Suhail, Ahmed, Pan, Genhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795331/
https://www.ncbi.nlm.nih.gov/pubmed/29361679
http://dx.doi.org/10.3390/s18010308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795331/
https://www.ncbi.nlm.nih.gov/pubmed/29361679
http://dx.doi.org/10.3390/s18010308

Ejemplares similares